MCID: HMR012
MIFTS: 56

Hemorrhagic Fever malady

Categories: Rare diseases, Infectious diseases

Aliases & Classifications for Hemorrhagic Fever

Summaries for Hemorrhagic Fever

MedlinePlus : 41 viral hemorrhagic fevers (vhfs) are a group of illnesses caused by four families of viruses. these include the ebola and marburg, lassa fever, and yellow fever viruses. vhfs have common features: they affect many organs, they damage the blood vessels, and they affect the body's ability to regulate itself. some vhfs cause mild disease, but some, like ebola or marburg, cause severe disease and death. vhfs are found around the world. specific diseases are usually limited to areas where the animals that carry them live. for example, lassa fever is limited to rural areas of west africa where rats and mice carry the virus. the risk for travelers is low, but you should avoid visiting areas where there are disease outbreaks. because there are no effective treatments for some of these viral infections, there is concern about their use in bioterrorism. centers for disease control and prevention

MalaCards based summary : Hemorrhagic Fever, also known as hemorrhagic fevers, viral, is related to dengue hemorrhagic fever and dengue disease, and has symptoms including fever and pruritus. An important gene associated with Hemorrhagic Fever is CD209 (CD209 Molecule), and among its related pathways/superpathways are Cytokine Signaling in Immune system and Influenza A. The drugs Benzocaine and Menthol have been mentioned in the context of this disorder. Affiliated tissues include endothelial, testes and t cells, and related phenotypes are homeostasis/metabolism and cardiovascular system

Related Diseases for Hemorrhagic Fever

Diseases in the Hemorrhagic Fever family:

Viral Hemorrhagic Fever

Diseases related to Hemorrhagic Fever via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 410)
id Related Disease Score Top Affiliating Genes
1 dengue hemorrhagic fever 33.6 IFNG IL10 TNF
2 dengue disease 32.8 IFNG IL10 IL6 TNF
3 rift valley fever 29.9 ALB IFNG IL6 TNF
4 hepatitis 29.8 HLA-DRB1 IFNG IL10 IL6 TNF
5 influenza 29.8 F2 F3 SERPINC1
6 labyrinthitis 29.5 IL10 IL6 TNF
7 venezuelan equine encephalitis 29.1 ALB B2M CD40LG
8 myocardial infarction 28.2 ALB F2 F3 IL10 IL6 ITGB3
9 crimean-congo hemorrhagic fever 12.5
10 omsk hemorrhagic fever 12.4
11 argentine hemorrhagic fever 12.4
12 hemorrhagic fever with renal syndrome 12.4
13 marburg hemorrhagic fever 12.3
14 ebola hemorrhagic fever 12.3
15 bolivian hemorrhagic fever 12.3
16 venezuelan hemorrhagic fever 12.3
17 alkhurma hemorrhagic fever 12.3
18 lujo hemorrhagic fever 12.3
19 korean hemorrhagic fever 12.3
20 viral hemorrhagic fever 12.2
21 brazilian hemorrhagic fever 12.2
22 chapare hemorrhagic fever 12.2
23 balkan hemorrhagic fever 12.1
24 whitewater arroyo hemorrhagic fever 12.1
25 kyasanur forest disease 11.6
26 lassa fever 11.6
27 nephropathia epidemica 11.1
28 hantavirus pulmonary syndrome 11.1
29 pancreatitis, hereditary 10.7
30 dengue fever, protection against 10.7
31 viral infectious disease 10.7
32 pyridoxal 5'-phosphate-dependent epilepsy 10.3 IL10 TNF
33 vps11-related autosomal recessive hypomyelinating leukodystrophy 10.3 IL6 TNF
34 tubular renal disease-cardiomyopathy syndrome 10.3 IL10 TNF
35 parovarian cyst 10.3 CD209 F2 TNF
36 hemarthrosis 10.3 F2 F3
37 transient tic disorder 10.3 IL10 IL6 TNF
38 hypoparathyroidism-retardation-dysmorphism syndrome 10.3 IL10 IL6 TNF
39 trichomalacia 10.3 IL10 IL6 TNF
40 phlyctenulosis 10.3 IL10 IL6 TNF
41 gastric dilatation 10.3 IL10 IL6 TNF
42 familial progressive hyperpigmentation 10.3 F2 GPT
43 rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies 10.3 IL10 IL6 TNF
44 gonococcal endophthalmia 10.2 IL10 IL6 TNF
45 autosomal recessive type iv ehlers-danlos syndrome 10.2 IL10 IL6 TNF
46 bladder signet ring cell adenocarcinoma 10.2 IL10 IL6 TNF
47 esophagus lymphoma 10.2 IFNG IL6 TNF
48 inappropriate adh syndrome 10.2 IL10 IL6 TNF
49 central nervous system lymphoma 10.2 IL10 IL6 TNF
50 severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive 10.2 IFNG IL10 TNF

Graphical network of the top 20 diseases related to Hemorrhagic Fever:



Diseases related to Hemorrhagic Fever

Symptoms & Phenotypes for Hemorrhagic Fever

UMLS symptoms related to Hemorrhagic Fever:


fever, pruritus

MGI Mouse Phenotypes related to Hemorrhagic Fever:

44 (show all 16)
id Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.27 ALB B2M CD40LG F2 F3 IFNG
2 cardiovascular system MP:0005385 10.26 B2M CD40LG F2 F3 IFNG IL10
3 cellular MP:0005384 10.25 ALB B2M CD40LG F3 IFNG IL10
4 hematopoietic system MP:0005397 10.25 B2M CD40LG F2 F3 GPT IFNG
5 immune system MP:0005387 10.18 B2M CD40LG F2 F3 IFNG IL10
6 mortality/aging MP:0010768 10.18 F3 IFNG IL10 IL6 ITGB3 SERPINC1
7 digestive/alimentary MP:0005381 10.14 IL6 ITGB3 TNF ALB B2M F2
8 integument MP:0010771 10.11 B2M CD40LG F2 F3 IFNG IL10
9 embryo MP:0005380 10.07 F2 F3 IFNG IL10 ITGB3 SERPINC1
10 liver/biliary system MP:0005370 10.03 ALB B2M IFNG IL10 IL6 ITGB3
11 nervous system MP:0003631 10 B2M CD40LG F2 F3 IFNG IL10
12 neoplasm MP:0002006 9.92 ALB B2M F3 IFNG IL10 IL6
13 muscle MP:0005369 9.91 TNF ALB F3 IFNG IL10 IL6
14 reproductive system MP:0005389 9.81 B2M CD40LG F2 IFNG IL10 IL6
15 respiratory system MP:0005388 9.5 F2 F3 IFNG IL10 IL6 ITGB3
16 vision/eye MP:0005391 9.23 F3 IFNG IL10 IL6 ITGB3 SERPINC1

Drugs & Therapeutics for Hemorrhagic Fever

Drugs for Hemorrhagic Fever (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 222)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzocaine Approved Phase 4,Phase 1,Phase 2 1994-09-7, 94-09-7 2337
2
Menthol Approved Phase 4 2216-51-5 16666
3
Histamine Approved, Investigational Phase 4 75614-87-8, 51-45-6 774
4
Ketotifen Approved Phase 4 34580-14-8, 34580-13-7 3827
5 tannic acid Approved, Nutraceutical Phase 4,Phase 1,Phase 2
6 Dermatologic Agents Phase 4,Phase 1,Phase 2
7 Vaccines Phase 4,Phase 2,Phase 3,Phase 1
8 Vasoconstrictor Agents Phase 4
9
Histamine Phosphate Phase 4 51-74-1 65513
10 Neurotransmitter Agents Phase 4
11 Histamine Antagonists Phase 4
12 Histamine H1 Antagonists Phase 4
13 Anti-Allergic Agents Phase 4
14 Antipruritics Phase 4
15
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1
16
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 1 50-02-2 5743
17
Doxorubicin Approved, Investigational Phase 3,Phase 2 23214-92-8 31703
18
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757 53477783
19
Vincristine Approved, Investigational Phase 3,Phase 2 2068-78-2, 57-22-7 5978
20
Loperamide Approved Phase 2, Phase 3 53179-11-6 3955
21
deoxycholic acid Approved Phase 3 83-44-3 222528
22
Busulfan Approved, Investigational Phase 3,Phase 1,Phase 2 55-98-1 2478
23
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
24
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
25
Norgestimate Approved Phase 3 35189-28-7 6540478
26
Vancomycin Approved Phase 3 1404-90-6 441141 14969
27
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
28
Tazobactam Approved Phase 3 89786-04-9 123630
29
Piperacillin Approved Phase 3 66258-76-2 43672
30
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
31
Nystatin Approved, Vet_approved Phase 3 1400-61-9 11953884
32
Prednisone Approved, Vet_approved Phase 3,Phase 1,Phase 2 53-03-2 5865
33
Ivermectin Approved, Vet_approved Phase 2, Phase 3 70288-86-7 6474909 46936176
34
Acetaminophen Approved Phase 2, Phase 3 103-90-2 1983
35
Hydroxyurea Approved Phase 3 127-07-1 3657
36
Anagrelide Approved Phase 3 68475-42-3 2182
37
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
38
rituximab Approved Phase 3,Phase 1,Phase 2 174722-31-7 10201696
39
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3 11103-57-4, 68-26-8 445354
40
Doxil Approved June 1999 Phase 3,Phase 2 31703
41 DEET Phase 3
42 Adjuvants, Immunologic Phase 3,Phase 2,Phase 1
43 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 1,Phase 2
44 Peripheral Nervous System Agents Phase 3,Phase 1,Phase 2
45 Pharmaceutical Solutions Phase 3,Phase 2,Phase 1
46 Immunoglobulins Phase 3,Phase 1,Phase 2
47 Anti-Infective Agents Phase 3,Phase 2,Phase 1
48 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
49 Protective Agents Phase 3,Phase 2,Phase 1
50 Insect Repellents Phase 3

Interventional clinical trials:

(show top 50) (show all 267)
id Name Status NCT ID Phase
1 High Frequency Ventilation During Off Pump Coronary Artery Bypass Graft (CABG) Completed NCT00863044 Phase 4
2 Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi Recruiting NCT02911415 Phase 4
3 Open Study of the Duration of Immunity After Vaccination With GamEvac Recruiting NCT02911428 Phase 4
4 Ketotifen as a Treatment for Vascular Leakage During Dengue Fever Recruiting NCT02673840 Phase 4
5 Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study) Recruiting NCT02555072 Phase 4
6 International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi Not yet recruiting NCT03072030 Phase 4
7 Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE) Not yet recruiting NCT02991495 Phase 4
8 Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals Not yet recruiting NCT03132311 Phase 4
9 Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS) Unknown status NCT00966628 Phase 3
10 Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR Unknown status NCT00938379 Phase 3
11 Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma Unknown status NCT00932217 Phase 3
12 STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) Completed NCT02378753 Phase 2, Phase 3
13 Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia Completed NCT01254422 Phase 3
14 Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS Completed NCT02360514 Phase 3
15 Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea Completed NCT02342171 Phase 2, Phase 3
16 Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers Completed NCT01411241 Phase 3
17 Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia Completed NCT01134263 Phase 3
18 Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers Completed NCT01436396 Phase 3
19 A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Completed NCT01466387 Phase 3
20 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3
21 Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer Completed NCT00002742 Phase 3
22 Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells Completed NCT00398411 Phase 3
23 Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Completed NCT00344422 Phase 3
24 A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. Completed NCT00300664 Phase 2, Phase 3
25 Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo Recruiting NCT02661464 Phase 3
26 Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® Recruiting NCT02979535 Phase 3
27 Efficacy and Safety of Ivermectin Against Dengue Infection Recruiting NCT02045069 Phase 2, Phase 3
28 Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2 Recruiting NCT02509494 Phase 3
29 Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine Recruiting NCT02406729 Phase 3
30 Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine. Recruiting NCT02699099 Phase 3
31 The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia Recruiting NCT02577926 Phase 3
32 Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia Active, not recruiting NCT01373281 Phase 3
33 Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America Active, not recruiting NCT01374516 Phase 3
34 Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) Active, not recruiting NCT02503202 Phase 3
35 The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient. Active, not recruiting NCT01426243 Phase 3
36 First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. Active, not recruiting NCT00801281 Phase 3
37 Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects Not yet recruiting NCT02992418 Phase 3
38 Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® Not yet recruiting NCT02993757 Phase 3
39 Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine Not yet recruiting NCT03161366 Phase 3
40 Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola) Withdrawn NCT02307591 Phase 2, Phase 3
41 Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms Unknown status NCT01973855 Phase 2
42 Treatment of Japanese Encephalitis Unknown status NCT00216268 Phase 2
43 Multiple Treatments for Ebola Virus Disease (EVD) Unknown status NCT02380625 Phase 1, Phase 2
44 The Effect of Chloroquine in the Treatment of Patients With Dengue Unknown status NCT00849602 Phase 1, Phase 2
45 Melatonin & Ulcerative Colitis Unknown status NCT00790478 Phase 2
46 Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever Completed NCT01601613 Phase 2
47 Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America Completed NCT01187433 Phase 2
48 A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines Completed NCT01064141 Phase 2
49 Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US Completed NCT00617344 Phase 2
50 Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India Completed NCT01550289 Phase 2

Search NIH Clinical Center for Hemorrhagic Fever

Genetic Tests for Hemorrhagic Fever

Anatomical Context for Hemorrhagic Fever

MalaCards organs/tissues related to Hemorrhagic Fever:

39
Endothelial, Testes, T Cells, Kidney, Monocytes, Liver, Heart

Publications for Hemorrhagic Fever

Articles related to Hemorrhagic Fever:

(show top 50) (show all 1757)
id Title Authors Year
1
Lack of association between integrin I+vI^3 gene polymorphisms and hemorrhagic fever with renal syndrome in Han Chinese from Hubei, China. ( 28190175 )
2017
2
Electron Microscopy of Alkhumra Hemorrhagic Fever Virus. ( 28051359 )
2017
3
Prevalence of hemorrhagic fever with renal syndrome in Qingdao City, China, 2010-2014. ( 27786303 )
2016
4
Systems Pharmacology Uncovers the Multiple Mechanisms of Xijiao Dihuang Decoction for the Treatment of Viral Hemorrhagic Fever. ( 27239215 )
2016
5
Crimean-Congo Hemorrhagic Fever in the One-Humped Camel (Camelus dromedarius) in East and Northeast of Iran. ( 27308275 )
2016
6
Seroprevalence of West Nile virus, Crimean-Congo hemorrhagic fever virus, Francisella tularensis and Borrelia burgdorferi in rural population of Manisa, western Turkey. ( 27353580 )
2016
7
Does Crimean-Congo Hemorrhagic Fever Cause a Vasculitic Reaction with Pulmonary Artery Enlargement and Acute Pulmonary Hypertension? ( 27344326 )
2016
8
Characterization of dengue virus infections in a sample of patients suggests unique clinical, immunological, and virological profiles that impact on the diagnosis of dengue and dengue hemorrhagic fever. ( 26990973 )
2016
9
The prognostic impact of platelet distribution width in patients with Crimean-Congo hemorrhagic fever. ( 27089100 )
2016
10
Phylogeographic analysis of hemorrhagic fever with renal syndrome patients using multiplex PCR-based next generation sequencing. ( 27221218 )
2016
11
Ebola hemorrhagic fever under scope, view of knowledge, attitude and practice from rural Sudan in 2015. ( 27396613 )
2016
12
Multi-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Fever. ( 27424492 )
2016
13
Characteristics and Risk Factors for Fatality in Patients with Dengue Hemorrhagic Fever, Taiwan, 2014. ( 27273649 )
2016
14
Crimean-Congo Hemorrhagic Fever Knowledge, Attitudes, Practices, Risk Factors, and Seroprevalence in Rural Georgian Villages with Known Transmission in 2014. ( 27336731 )
2016
15
Crimean-Congo hemorrhagic fever among children in Iran. ( 27878461 )
2016
16
A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus. ( 27713073 )
2016
17
Relationship between IFNA1, IFNA5, IFNA10, and IFNA17 gene polymorphisms and Crimean-Congo hemorrhagic fever prognosis in a Turkish population range. ( 26694082 )
2016
18
History of incomplete vaccination may associate with occurrence of hemorrhagic fever with renal syndrome with relieved clinical symptoms. ( 26636561 )
2016
19
Determination of nasal mucociliary clearance time and nasal symptom in patients with crimean-congo hemorrhagic fever. ( 27813123 )
2016
20
Changes in Plasma Adiponectin Concentrations in Patients With Hemorrhagic Fever With Renal Syndrome: An Observational Prospective Study. ( 26871804 )
2016
21
Crimean-Congo Hemorrhagic Fever in Dubai, United Arab Emirates, 2010: Case Report. ( 27795839 )
2016
22
50 Years Ago in TheJournal ofPediatrics: Shock Associated with Dengue Infection: I. Clinical and Physiological Manifestations of Dengue Hemorrhagic Fever in Thailand, 1964. ( 26922761 )
2016
23
Interleukin-10 as a Marker of Disease Progression in Dengue Hemorrhagic Fever. ( 26975948 )
2016
24
Time Series Analysis of Hemorrhagic Fever with Renal Syndrome: A Case Study in Jiaonan County, China. ( 27706256 )
2016
25
Phylogeography of Crimean Congo Hemorrhagic Fever Virus. ( 27880794 )
2016
26
Biosafety standards for working with Crimean-Congo hemorrhagic fever virus. ( 27667586 )
2016
27
PRESEPSIN LEVELS OF PATIENTS WITH CRIMEAN-CONGO HEMORRHAGIC FEVER. ( 27000451 )
2016
28
Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever. ( 27353587 )
2016
29
Evidence for widespread infection of African bats with Crimean-Congo hemorrhagic fever-like viruses. ( 27217069 )
2016
30
The Epi Info Viral Hemorrhagic Fever (VHF) Application: A Resource for Outbreak Data Management and Contact Tracing in the 2014-2016 West Africa Ebola Epidemic. ( 27587635 )
2016
31
Epidemiological analysis of hemorrhagic fever with renal syndrome in China with the seasonal-trend decomposition method and the exponential smoothing model. ( 27976704 )
2016
32
Prevalence of hemorrhagic fever with renal syndrome in Yiyuan County, China, 2005-2014. ( 26852019 )
2016
33
The assessment of Hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in northwest China. ( 27824286 )
2016
34
Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus. ( 27110812 )
2016
35
Spatio-Temporal Pattern and Influencing Factors of Hemorrhagic Fever with Renal Syndrome (HFRS) in Hubei Province (China) between 2005 and 2014. ( 28030550 )
2016
36
A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies. ( 27623345 )
2016
37
Updates in diagnosis and management of Ebola hemorrhagic fever. ( 28163730 )
2016
38
Crimean-Congo Hemorrhagic Fever with Acute Subdural Hematoma, Mauritania, 2012. ( 27315138 )
2016
39
Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever. ( 26792737 )
2016
40
The prognostic significance of serum TGF-I^1 levels in patients with Crimean-Congo hemorrhagic fever. ( 27467498 )
2016
41
A retrospective controlled study of thiol disulfide homeostasis as a novel marker in Crimean Congo hemorrhagic fever. ( 27159644 )
2016
42
Hemorrhagic Fever with Renal Syndrome: Pathogenesis and Clinical Picture. ( 26870699 )
2016
43
Molecular analysis of Crimean-Congo hemorrhagic fever virus and Rickettsia in Hyalomma marginatum ticks removed from patients (Spain) and birds (Spain and Morocco), 2009-2015. ( 27215620 )
2016
44
Crimean-Congo hemorrhagic fever virus in livestock ticks and animal handler seroprevalence at an abattoir in Ghana. ( 27392037 )
2016
45
Protective role of host aquaporin 6 against Hazara virus, a model for Crimean-Congo hemorrhagic fever virus infection. ( 26976854 )
2016
46
Phylogeny of tick-derived Crimean-Congo hemorrhagic fever virus strains in Iran. ( 27491289 )
2016
47
Lujo viral hemorrhagic fever: considering diagnostic capacity and preparedness in the wake of recent Ebola and Zika virus outbreaks. ( 27593704 )
2016
48
A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever. ( 27976688 )
2016
49
Possible sexual transmission of Crimean-Congo hemorrhagic fever. ( 26972040 )
2016
50
Molecular Assay on Crimean Congo Hemorrhagic Fever Virus in Ticks (Ixodidae) Collected from Kermanshah Province, Western Iran. ( 27308296 )
2016

Variations for Hemorrhagic Fever

Expression for Hemorrhagic Fever

Search GEO for disease gene expression data for Hemorrhagic Fever.

Pathways for Hemorrhagic Fever

Pathways related to Hemorrhagic Fever according to GeneCards Suite gene sharing:

(show all 38)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.26 B2M CD40LG HLA-DRB1 IFNG IL10 IL6
2
Show member pathways
12.75 CD209 HLA-DRB1 IFNG IL6 TNF
3
Show member pathways
12.69 B2M CD40LG HLA-DRB1 IFNG IL10 IL6
4
Show member pathways
12.58 CD40LG HLA-DRB1 IFNG IL10 TNF
5
Show member pathways
12.55 HLA-DRB1 IFNG IL10 IL6 TNF
6
Show member pathways
12.54 F2 IFNG IL10 IL6 TNF
7 12.48 B2M CD40LG IFNG IL10 TNF
8
Show member pathways
12.37 CD40LG IFNG IL10 IL6 TNF
9
Show member pathways
12.23 ALB F2 IFNG IL6 TNF
10
Show member pathways
12.13 CD40LG HLA-DRB1 IFNG IL10 TNF
11
Show member pathways
12.1 IFNG IL10 IL6 TNF
12 11.99 CD209 HLA-DRB1 IFNG IL10 IL6 TNF
13
Show member pathways
11.9 B2M HLA-DRB1 IFNG
14
Show member pathways
11.9 IFNG IL10 IL6 TNF
15 11.84 F3 IL6 TNF
16 11.82 HLA-DRB1 IL6 ITGB3 TNF
17 11.81 IFNG IL10 IL6 TNF
18 11.77 HLA-DRB1 IFNG IL6 TNF
19 11.75 IFNG IL10 TNF
20
Show member pathways
11.72 CD40LG IFNG TNF
21 11.72 IL10 IL6 TNF
22 11.66 IFNG IL10 IL6
23 11.63 CD40LG IL10 ITGB3
24 11.62 CD40LG IL10 IL6 TNF
25
Show member pathways
11.61 B2M IFNG TNF
26 11.6 CD209 IFNG IL10 IL6 TNF
27
Show member pathways
11.53 CD40LG IFNG IL6 TNF
28 11.52 IFNG IL6 TNF
29 11.5 IL10 IL6 TNF
30 11.5 CD209 IFNG IL10 IL6 ITGB3 TNF
31 11.45 IFNG IL6 TNF
32
Show member pathways
11.4 IFNG IL10 TNF
33 11.32 IL10 IL6 TNF
34 11.26 IFNG IL6 TNF
35 11.24 CD40LG IFNG IL10 IL6 TNF
36 11.21 IFNG IL10 IL6 TNF
37 11.17 CD40LG IL10 IL6 TNF
38 10.5 HLA-DRB1 IFNG IL10 IL6 TNF

GO Terms for Hemorrhagic Fever

Cellular components related to Hemorrhagic Fever according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.9 ALB B2M CD209 CD40LG F2 F3
2 cell surface GO:0009986 9.8 B2M CD209 CD40LG F3 HLA-DRB1 ITGB3
3 endoplasmic reticulum lumen GO:0005788 9.72 ALB B2M F2 IL6 SERPINC1
4 extracellular space GO:0005615 9.7 ALB B2M CD40LG F2 F3 GPT
5 external side of plasma membrane GO:0009897 9.23 B2M CD209 CD40LG F2 HLA-DRB1 IFNG
6 extracellular exosome GO:0070062 10.02 ALB B2M CD209 F2 F3 GPT

Biological processes related to Hemorrhagic Fever according to GeneCards Suite gene sharing:

(show all 37)
id Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.97 B2M IFNG IL10 IL6
2 blood coagulation GO:0007596 9.87 F2 F3 ITGB3 SERPINC1
3 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091 9.84 IL10 IL6 TNF
4 viral entry into host cell GO:0046718 9.82 CD209 HLA-DRB1 ITGB3
5 positive regulation of protein kinase B signaling GO:0051897 9.82 F3 IL6 TNF
6 response to glucocorticoid GO:0051384 9.81 IL10 IL6 TNF
7 positive regulation of protein phosphorylation GO:0001934 9.81 F2 IFNG ITGB3 TNF
8 defense response to Gram-positive bacterium GO:0050830 9.8 B2M IL6 TNF
9 interferon-gamma-mediated signaling pathway GO:0060333 9.8 B2M HLA-DRB1 IFNG
10 positive regulation of endothelial cell proliferation GO:0001938 9.78 F3 IL10 ITGB3
11 positive regulation of T cell proliferation GO:0042102 9.77 CD40LG IFNG IL6
12 humoral immune response GO:0006959 9.75 IFNG IL6 TNF
13 antigen processing and presentation GO:0019882 9.73 CD209 HLA-DRB1 IFNG
14 platelet activation GO:0030168 9.73 CD40LG F2 IL6 ITGB3
15 hemostasis GO:0007599 9.72 F2 F3 SERPINC1
16 cellular protein metabolic process GO:0044267 9.72 ALB B2M F2 IL6 SERPINC1
17 positive regulation of nitric oxide biosynthetic process GO:0045429 9.7 IFNG IL6 TNF
18 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.67 IFNG TNF
19 cellular response to hepatocyte growth factor stimulus GO:0035729 9.67 IL10 IL6
20 response to molecule of bacterial origin GO:0002237 9.66 B2M IL10
21 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.65 IL10 TNF
22 positive regulation of protein import into nucleus, translocation GO:0033160 9.65 IFNG IL6
23 positive regulation of chemokine biosynthetic process GO:0045080 9.64 IFNG TNF
24 endothelial cell apoptotic process GO:0072577 9.62 IL10 TNF
25 positive regulation of MHC class II biosynthetic process GO:0045348 9.61 IFNG IL10
26 negative regulation of cytokine secretion involved in immune response GO:0002740 9.59 IL10 TNF
27 epithelial cell proliferation involved in salivary gland morphogenesis GO:0060664 9.58 IL6 TNF
28 regulation of immunoglobulin secretion GO:0051023 9.54 CD40LG TNF
29 defense response to protozoan GO:0042832 9.54 IFNG IL10 IL6
30 receptor biosynthetic process GO:0032800 9.49 IL10 TNF
31 neutrophil apoptotic process GO:0001781 9.48 IFNG IL6
32 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.46 IFNG TNF
33 negative regulation of growth of symbiont in host GO:0044130 9.43 IFNG IL10 TNF
34 positive regulation of vitamin D biosynthetic process GO:0060557 9.4 IFNG TNF
35 cellular response to lipopolysaccharide GO:0071222 9.35 B2M IFNG IL10 IL6 TNF
36 negative regulation of lipid storage GO:0010888 9.33 IL6 ITGB3 TNF
37 immune response GO:0006955 9.17 B2M CD40LG HLA-DRB1 IFNG IL10 IL6

Molecular functions related to Hemorrhagic Fever according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 virus receptor activity GO:0001618 9.33 CD209 HLA-DRB1 ITGB3
2 protease binding GO:0002020 9.26 F3 ITGB3 SERPINC1 TNF
3 cytokine activity GO:0005125 9.02 CD40LG IFNG IL10 IL6 TNF

Sources for Hemorrhagic Fever

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....